These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18369598)

  • 1. Levetiracetam as monotherapy or add-on to valproate in the treatment of acute mania-a randomized open-label study.
    Krüger S; Sarkar R; Pietsch R; Hasenclever D; Bräunig P
    Psychopharmacology (Berl); 2008 Jun; 198(2):297-9. PubMed ID: 18369598
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant levetiracetam in adolescent mania.
    Desarkar P; Das B; Sinha VK
    J Clin Psychopharmacol; 2007 Apr; 27(2):215-6. PubMed ID: 17414251
    [No Abstract]   [Full Text] [Related]  

  • 4. Landau-Kleffner syndrome responsive to levetiracetam.
    Kossoff EH; Boatman D; Freeman JM
    Epilepsy Behav; 2003 Oct; 4(5):571-5. PubMed ID: 14527502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam for acute mania.
    Goldberg JF; Burdick KE
    Am J Psychiatry; 2002 Jan; 159(1):148. PubMed ID: 11772709
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of levetiracetam to decrease mania in elderly bipolar patients.
    Kyomen HH
    Am J Geriatr Psychiatry; 2006 Nov; 14(11):985. PubMed ID: 17068322
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich GS; Kupka R; Nolen WA; Luckenbaugh DA; Walden J; Grunze H
    J Clin Psychiatry; 2005 Mar; 66(3):370-4. PubMed ID: 15766304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in the treatment of rapid cycling bipolar disorder.
    Bräunig P; Krüger S
    J Psychopharmacol; 2003 Jun; 17(2):239-41. PubMed ID: 12870574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsants in the treatment of bipolar disorder.
    Keck PE; McElroy SL; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):395-405. PubMed ID: 1422166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
    Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
    Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
    Paul F; Meencke HJ
    Epilepsia; 2004 May; 45(5):559-60. PubMed ID: 15101839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
    Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
    CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
    Neyens LG; Alpherts WC; Aldenkamp AP
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):411-9. PubMed ID: 7624492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychic disturbances associated with sodium valproate plus levetiracetam.
    Siniscalchi A; Gallelli L; De Fazio S; De Sarro G
    Ann Pharmacother; 2007 Mar; 41(3):527-8. PubMed ID: 17327289
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.
    Bertsche A; Neininger MP; Dahse AJ; Syrbe S; Bernhard MK; Frontini R; Kiess W; Bertsche T; Merkenschlager A
    Eur J Pediatr; 2014 Jan; 173(1):87-92. PubMed ID: 23933673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy treatment of bipolar disorder with levetiracetam.
    Kaufman KR
    Epilepsy Behav; 2004 Dec; 5(6):1017-20. PubMed ID: 15582854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A; Velizarova R; Genton P; Gélisse P
    Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.